Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...

Thermo Fisher Scientific (NYSE:TMO – Free Report) had its price objective upped by UBS Group from $700.00 to $715.00 in a research note released on Friday morning,Benzinga reports. The brokerage ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $654.0, with a high estimate of $680.00 and a low estimate of $605.00. Experiencing a 1.36% ...

Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 4.7% year on year to $11.4 billion. Its non-GAAP profit of $6.10 per ...

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) will likely be issuing its quarterly earnings data before the market opens on Thursday, January 30th. Analysts expect the company to announce ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a 10-year virtual power purchasing agreement (VPPA) with international renewable energy developer X-ELIO ...

It's the second time in less than three months that the Waltham-based life sciences firm has announced layoffs.

Good morning, ladies and gentlemen, and welcome to the Thermo Fisher ... Scientific Iliad scanning from transmission electron microscope, which integrates a number of advanced analytical ...

Earlier this week, Franco-German peer Sartorius reported preliminary annual results that beat expectations and posted a 23.1% ...

Stifel Nicolaus analyst Daniel Arias maintained a Buy rating on Thermo Fisher (TMO – Research Report) today and set a price target of $665.00.

Strong demand, biotech funding optimism, and a bold 2025 outlook fuel investor confidence--here's what you need to know.